
Publication|Articles|July 23, 2024
Peers & Perspectives in Oncology
- July 2024
- Pages: 68
Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer
Author(s)Targeted Oncology Staff
In separate, live virtual events, Michael J. Birrer, MD, PhD, and Jubilee Brown, MD, surveyed participants on the treatment of a postmenopausal woman with stage IVA endometrial cancer after first-line chemotherapy.
Advertisement
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Alpelisib/Fulvestrant Improves PFS in Post-CDK4/6 HR+/HER2- Breast Cancer
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
HRT Shows No Adverse Effect on Breast Cancer Risk in Patients With BRCA Variant
5










































